國立高雄大學圖資館 |

登入

回首頁

Companion diagnostics (CDx) in precision medicine

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Companion diagnostics (CDx) in precision medicineedited by Il-Jin Kim.
其他作者:	Kim, Il-Jin.
出版者:	Singapore :Pan Stanford Publishing,c2019.
面頁冊數:	1 online resource.
標題:	CancerTreatment.
電子資源:	https://www.taylorfrancis.com/books/9780429275906
ISBN:	9780429275906$q(electronic bk.)

Companion diagnostics (CDx) in precision medicine
Companion diagnostics (CDx) in precision medicine[electronic resource] /edited by Il-Jin Kim. - Singapore :Pan Stanford Publishing,c2019. - 1 online resource.

Includes bibliographical references and index.

There is a new trend in anti-cancer therapeutics development: a targeted therapy and precision medicine that targets a subgroup of patients with specific biomarkers. An in vitro diagnostic (IVD) assay is required to identify a subgroup of cancer patients who would benefit from the targeted therapy, or not likely benefit, or have a high risk of side effects from the specific drug treatment. This IVD or medical device is called a companion diagnostic (CDx) assay. It is key to have a robust CDx assay or device for the success of targeted therapy and precision medicine. This book covers the technical, historical, clinical, and regulatory aspects of CDx in precision medicine. Clearly, more and more newly developed oncology drugs will require accompanying CDx assays, and this book, with chapters contributed by renowned oncologists, provides a comprehensive foundation for the knowledge and application of CDx for precision medicine.

ISBN: 9780429275906$q(electronic bk.)Subjects--Topical Terms:

252269
Cancer
--Treatment.

LC Class. No.: RC263

Dewey Class. No.: 616.99/4

Companion diagnostics (CDx) in precision medicine
LDR:02233cmm a2200373 a 4500 001 624117
003 FlBoTFG
005 20190327110706.0
006 m o d
007 cr cnu---unuuu
008 221226s2019 si ob 001 0 eng d
020 $a 9780429275906$q(electronic bk.)
020 $a 0429275900$q(electronic bk.)
020 $a 9780415000383$q(electronic bk.)
020 $a 0415000386$q(electronic bk.)
020 $a 9781000000382$q(electronic bk. ;$qPDF)
020 $a 1000000389$q(electronic bk. ;$qPDF)
020 $a 9781000013740$q(electronic bk. ;$qMobipocket)
020 $a 100001374X$q(electronic bk. ;$qMobipocket)
020 $a 9781000007213$q(electronic bk. ;$qEPUB)
020 $a 1000007219$q(electronic bk. ;$qEPUB)
020 $z 9789814800235
020 $z 9814800236
035 $a 9780429275906
040 $a OCoLC-P $b eng $c OCoLC-P
041 0 $a eng
050 4 $a RC263
082 0 4 $a 616.99/4 $2 23
245 0 0 $a Companion diagnostics (CDx) in precision medicine $h [electronic resource] / $c edited by Il-Jin Kim.
260 $a Singapore : $b Pan Stanford Publishing, $c c2019.
300 $a 1 online resource.
504 $a Includes bibliographical references and index.
520 $a There is a new trend in anti-cancer therapeutics development: a targeted therapy and precision medicine that targets a subgroup of patients with specific biomarkers. An in vitro diagnostic (IVD) assay is required to identify a subgroup of cancer patients who would benefit from the targeted therapy, or not likely benefit, or have a high risk of side effects from the specific drug treatment. This IVD or medical device is called a companion diagnostic (CDx) assay. It is key to have a robust CDx assay or device for the success of targeted therapy and precision medicine. This book covers the technical, historical, clinical, and regulatory aspects of CDx in precision medicine. Clearly, more and more newly developed oncology drugs will require accompanying CDx assays, and this book, with chapters contributed by renowned oncologists, provides a comprehensive foundation for the knowledge and application of CDx for precision medicine.
588 $a Description based on print version record.
650 0 $a Cancer $x Treatment. $3 252269
650 0 $a Personalized medicine. $3 713807
700 1 $a Kim, Il-Jin. $3 926447
856 4 0 $u https://www.taylorfrancis.com/books/9780429275906